You are here

Article Text

Article menu

Download PDFPDF

Miscellaneous
Editorial Notice
Free

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In the May 2003 issue of Thorax we published a paper by Brusasco and colleagues on the subject of health outcomes following treatment with tiotropium.1 This paper reported the results of two 6 month studies that were combined for the purpose of analysis in this paper. One of these studies had been previously published by Donohue et al in Chest and not referenced by Brusasco and colleagues.2Thorax wishes to bring the overlap between these two papers to the attention of readers.

    References

    1. ↵
      Brusasco V, Hodder R, Miravitlles M, Korducli L, Towse L, Kesten S. Health outcomes following treatment with tiotropium compared with twice daily salmeterol in patients with COPD. Thorax2003;58:399–401.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ, Kesten S, Towse L. A 6-month, placebo- controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest2002;122:47–55.
      OpenUrlCrossRefPubMedWeb of Science